Cavendish Lifts Optima Health Target Following Annual Profit Beat

Key Facts

In a move reflecting strong operational momentum within the occupational health sector, brokerage firm Cavendish has raised its price target for Optima Health PLC. The upward revision follows the company's report of adjusted EBITDA reaching £20.1 million for the fiscal year ending in March. According to analyst reports, these earnings exceeded Cavendish's own estimates by 12% and outperformed wider market expectations by 10%, signaling robust profitability.

This financial performance underscores growing confidence in the company's ability to meet its medium-term financial objectives. Analysts noted that the earnings beat was driven by a material improvement in underlying profitability throughout the year. Consequently, the stronger-than-expected fiscal results have prompted a more bullish valuation from Cavendish as the company cements its position in the healthcare services market.

As of the market snapshot on August 17, 2026, specific price levels for OPT remain unavailable in the current data set, suggesting investors should focus on qualitative directional trends following the upgrade. Looking ahead, UK market participants will be monitoring the BRC Retail Sales Monitor for broader economic context regarding the domestic business environment in which Optima Health operates.